The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How to Manage, Treat Anemia of Inflammation in Patients with Rheumatic Disease

How to Manage, Treat Anemia of Inflammation in Patients with Rheumatic Disease

December 17, 2017 • By Ruth Jessen Hickman, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

In anemia of inflammation, high concentrations of hepcidin triggered by IL-6, TNF-α and other cytokines cause reticuloendothelial cells to sequester iron, via hepcidin. This leads to iron-restricted erythropoiesis, even though bodily supplies of iron are adequate. Inflammatory mediators also trigger shortened red blood cell survival and blunted production of erythropoietin.5

You Might Also Like
  • How to Manage Patients with Giant Cell Arteritis and Polymyalgia Rheumatica
  • Plasma Complement Activation in Rheumatic Diseases May Accelerate Coronary Artery Disease
  • Pediatric Rheumatology Research Highlights Successful Approaches to Manage Juvenile Rheumatic Diseases
Explore This Issue
December 2017
Also By This Author
  • New Study: Does Urate-Lowering Therapy Reduce Gout-Patient Mortality?

Workup/Diagnosis of Anemia

Anemia is diagnosed on the basis of reduced hemoglobin concentrations (<12 g/dL for women and <13 g/dL for men). Standard analyses include mean corpuscular hemoglobin (MCH), mean corpuscular volume (MCV), reticulocyte count, peripheral smear and iron markers, such as serum iron, ferritin, transferrin and transferrin saturation. A standard workup should also include renal function tests, haptoglobin and lactate dehydrogenase (to screen for hemolysis), as well as folic acid, B12 and vitamin D to rule out vitamin deficiencies. Other tests may be needed if clinically suspected or if further investigation is required.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Weiss notes that the proper diagnosis of anemia in these patients can be challenging. “Apart from the underlying rheumatic disease, other pathophysiological mechanisms or disorders may contribute to anemia which need to be identified and treated. One major problem in treating such patients is the lack of good surrogate markers, which can correctly identify true iron deficiency in the setting of inflammation.”

For rheumatologists, one of the most common problems is distinguishing anemia of inflammation, true iron-deficiency anemia and anemia with both components. In both iron-deficiency anemia and anemia of inflammation, both serum iron and transferrin saturation are reduced. In anemia of inflammation, the concentration of ferritin is normal or increased and circulating transferrin is low. This contrasts with iron-deficiency anemia, in which ferritin is low and transferrin is normal to increased.1,5

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Traditionally, marrow iron staining has been used to distinguish the two entities in cases of diagnostic uncertainty. Anemia with inflammation reveals stainable iron in bone marrow macrophages, whereas iron-deficiency anemia does not. However, this test has been criticized due to its invasive and qualitative nature, and because iron therapy sometimes causes marrow iron deposition that may be poorly bioavailable. Measures of serum ferritin have largely replaced this measure, but ferritin may be influenced by iron loading and inflammation, making it difficult to diagnose true iron deficiency if inflammation is also present.1,5 As a rule of thumb, a ferritin concentration greater than 150 ng/mL is rare in anemia of inflammation concomitant with absolute iron deficiency.

Researchers have developed newer clinical markers, including soluble transferrin receptor (sTfR) in serum, an indicator of the needs of iron for erythropoiesis. However, the test has some limits in clinical utility because of a lack of standardization, and because age, ethnicity and inflammation influence its normal range.1

Pages: 1 2 3 4 5 6 7 8 | Single Page

Filed Under: Conditions Tagged With: anemia, Cause, Clinical, Diagnosis, inflammation, kidney, macrocytic anemia, Management, outcome, pathophysiology, patient care, Rheumatic Disease, rheumatologist, rheumatology, systemic inflammatory syndrome, Test, Treatment, vitamin deficiencyIssue: December 2017

You Might Also Like:
  • How to Manage Patients with Giant Cell Arteritis and Polymyalgia Rheumatica
  • Plasma Complement Activation in Rheumatic Diseases May Accelerate Coronary Artery Disease
  • Pediatric Rheumatology Research Highlights Successful Approaches to Manage Juvenile Rheumatic Diseases
  • Long-Term Benefits, Risks of Biologic Disease-Modifying Anti-Rheumatic Drugs in Patients with RA

About Ruth Jessen Hickman, MD

Ruth Jessen Hickman, MD, was born and raised in eastern Kentucky, where she first cultivated her love of literature, writing and personal narratives. She attended Kenyon college, where she received a Bachelor of Arts in philosophy, summa cum laude. She worked with individuals with psychiatric conditions and later in a neuroscience lab at the University of Illinois, Chicago, before graduating from Indiana University Medical School in 2011. Instead of pursuing clinical medicine, Ruth opted to build on her strength of clearly explaining medical topics though a career as a freelance medical writer, writing both for lay people and for health professionals. She writes across the biomedical sciences, but holds strong interests in rheumatology, neurology, autoimmune diseases, genetics, and the intersection of broader social, cultural and emotional contexts with biomedical topics. Ruth now lives in Bloomington, Ind., with her husband, son and cat. She can be contacted via her website at ruthjessenhickman.com.

View more by this author»

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)